These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14599684)

  • 1. Evaluation of a line probe assay for identification of hepatitis B virus precore variants in serum from chronic hepatitis B carriers.
    Cameron-Wilson CL; Muir P; Ballard AL; Corden S; Boxall EH; Sablon E; Stuyver L
    J Virol Methods; 2003 Dec; 114(1):97-103. PubMed ID: 14599684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations.
    Olivero A; Ciancio A; Abate ML; Gaia S; Smedile A; Rizzetto M
    J Viral Hepat; 2006 Jun; 13(6):355-62. PubMed ID: 16842437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays.
    Zampino R; Marrone A; Finnström N; Eriksson T; Törmänen V; Hedrum A; Attanasio V; Rosario P; Utili R; Ruggiero G
    Infez Med; 2005 Jun; 13(2):86-96. PubMed ID: 16220028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of precore mutants of hepatitis B in the United Kingdom.
    Ballard AL; Boxall EH
    J Med Virol; 2000 Dec; 62(4):463-70. PubMed ID: 11074475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients.
    Laras A; Koskinas J; Avgidis K; Hadziyannis SJ
    J Viral Hepat; 1998 Jul; 5(4):241-8. PubMed ID: 9751010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sanger sequencing versus INNO-LiPA® HBV PreCore assay for routine detection of precore and basal core promoter mutations in hepatitis virus B chronically infected patients.
    Alidjinou EK; Bocket L; Pigot V; Lambert V; Hallaert C; Canva V; Hober D
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):277-279. PubMed ID: 29310947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
    Osiowy C; Villeneuve JP; Heathcote EJ; Giles E; Borlang J
    J Clin Microbiol; 2006 Jun; 44(6):1994-7. PubMed ID: 16757589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants.
    Hussain M; Chu CJ; Sablon E; Lok AS
    J Clin Microbiol; 2003 Aug; 41(8):3699-705. PubMed ID: 12904378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HBV precore/core promoter variants in the United States.
    Chu CJ; Keeffe EB; Han SH; Perrillo RP; Min AD; Soldevila-Pico C; Carey W; Brown RS; Luketic VA; Terrault N; Lok AS;
    Hepatology; 2003 Sep; 38(3):619-28. PubMed ID: 12939588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
    Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
    J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
    Watanabe K; Takahashi T; Takahashi S; Okoshi S; Ichida T; Aoyagi Y
    J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct types of hepatitis B virus core promoter variants in Yemeni blood donors.
    Sallam TA; Tong CY
    J Med Virol; 2002 Nov; 68(3):328-34. PubMed ID: 12226818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
    Lok AS; Zoulim F; Locarnini S; Mangia A; Niro G; Decraemer H; Maertens G; Hulstaert F; De Vreese K; Sablon E
    J Clin Microbiol; 2002 Oct; 40(10):3729-34. PubMed ID: 12354872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis.
    Liu CJ; Kao JH; Lai MY; Chen PJ; Chen DS
    J Med Virol; 2004 Apr; 72(4):545-50. PubMed ID: 14981756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified PCR protocols for INNO-LiPA HBV Genotyping and INNO-LiPA HBV PreCore assays.
    Qutub MO; Germer JJ; Rebers SP; Mandrekar JN; Beld MG; Yao JD
    J Clin Virol; 2006 Nov; 37(3):218-21. PubMed ID: 16973411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.
    Mese S; Arikan M; Cakiris A; Abaci N; Gumus E; Kursun O; Onel D; Ustek D; Kaymakoglu S; Badur S; Yenen OS; Bozkaya E
    J Gen Virol; 2013 Dec; 94(Pt 12):2729-2738. PubMed ID: 24045109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation.
    Ben-Ari Z; Ashur Y; Daudi N; Shmilovitz-Wiess H; Brown M; Sulkes J; Klein A; Mor E; Tur-Kaspa R; Shouval D
    Clin Transplant; 2004 Aug; 18(4):415-22. PubMed ID: 15233819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.
    Abbas Z; Muzaffar R; Siddiqui A; Naqvi SA; Rizvi SA
    BMC Gastroenterol; 2006 Jul; 6():20. PubMed ID: 16863587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic hepatitis B virus infection.
    Basaras M; Arrese E; Blanco S; Arroyo LS; Ruiz P; Cisterna R
    Intervirology; 2013; 56(3):190-4. PubMed ID: 23594698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.